Pharmacogenomic study of heart failure and candesartan response from the CHARM programme
View ORCID ProfileMarie-Pierre Dubé, Olympe Chazara, Audrey Lemaçon, Géraldine Asselin, Sylvie Provost, Amina Barhdadi, Louis-Philippe Lemieux Perreault, Ian Mongrain, Quanli Wang, Keren Carss, Dirk S Paul, Jonathan W Cunningham, Jean Rouleau, Scott D Solomon, John J V McMurray, Salim Yusuf, Chris B Granger, Carolina Haefliger, Simon de Denus, View ORCID ProfileJean-Claude Tardif
doi: https://doi.org/10.1101/2021.09.28.21263908
Marie-Pierre Dubé
1Montreal Heart Institute, Montreal, Canada
2Université de Montréal Beaulieu-Saucier Pharmacogenomics Centre, Montreal, Canada
3Université de Montréal, Faculty of Medicine, Department of medicine, Université de Montréal, Montreal, Canada
Ph.D.Olympe Chazara
4Centre for Genomics Research (CGR), Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
Ph.D.Audrey Lemaçon
1Montreal Heart Institute, Montreal, Canada
2Université de Montréal Beaulieu-Saucier Pharmacogenomics Centre, Montreal, Canada
3Université de Montréal, Faculty of Medicine, Department of medicine, Université de Montréal, Montreal, Canada
Ph.D.Géraldine Asselin
1Montreal Heart Institute, Montreal, Canada
2Université de Montréal Beaulieu-Saucier Pharmacogenomics Centre, Montreal, Canada
M.Sc.Sylvie Provost
1Montreal Heart Institute, Montreal, Canada
2Université de Montréal Beaulieu-Saucier Pharmacogenomics Centre, Montreal, Canada
M.Sc.Amina Barhdadi
1Montreal Heart Institute, Montreal, Canada
2Université de Montréal Beaulieu-Saucier Pharmacogenomics Centre, Montreal, Canada
Ph.D.Louis-Philippe Lemieux Perreault
1Montreal Heart Institute, Montreal, Canada
2Université de Montréal Beaulieu-Saucier Pharmacogenomics Centre, Montreal, Canada
Ph.D.Ian Mongrain
1Montreal Heart Institute, Montreal, Canada
2Université de Montréal Beaulieu-Saucier Pharmacogenomics Centre, Montreal, Canada
M.Sc.Quanli Wang
4Centre for Genomics Research (CGR), Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
Ph.D.Keren Carss
4Centre for Genomics Research (CGR), Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
Ph.D.Dirk S Paul
4Centre for Genomics Research (CGR), Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
Ph.D.Jonathan W Cunningham
5Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA USA
M.D.Jean Rouleau
1Montreal Heart Institute, Montreal, Canada
3Université de Montréal, Faculty of Medicine, Department of medicine, Université de Montréal, Montreal, Canada
M.D.Scott D Solomon
5Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA USA
M.D.John J V McMurray
6BHF Cardiovascular Research Centre University of Glasgow, Glasgow, UK
M.D.Salim Yusuf
7The Population Health Research Institute, Hamilton Health Sciences and the School of Rehabilitation Science, McMaster University, Hamilton, ON, Canada
M.D.Chris B Granger
8Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
M.D.Carolina Haefliger
4Centre for Genomics Research (CGR), Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
Ph.D.Simon de Denus
1Montreal Heart Institute, Montreal, Canada
2Université de Montréal Beaulieu-Saucier Pharmacogenomics Centre, Montreal, Canada
9Université de Montréal, Faculty of Pharmacy, Montreal, Canada
B. Pharm Ph.D.Jean-Claude Tardif
1Montreal Heart Institute, Montreal, Canada
3Université de Montréal, Faculty of Medicine, Department of medicine, Université de Montréal, Montreal, Canada
M.D.Data Availability
The data underlying this article cannot be shared publicly to preserve the privacy of study participants. The analytic methods and study materials may be made available to other researchers for purposes of reproducing the results or replicating the procedure. Summary statistics from the GWAS analyses are available publicly for visualisation and download at https://pheweb.statgen.org/charm
Posted September 29, 2021.
Pharmacogenomic study of heart failure and candesartan response from the CHARM programme
Marie-Pierre Dubé, Olympe Chazara, Audrey Lemaçon, Géraldine Asselin, Sylvie Provost, Amina Barhdadi, Louis-Philippe Lemieux Perreault, Ian Mongrain, Quanli Wang, Keren Carss, Dirk S Paul, Jonathan W Cunningham, Jean Rouleau, Scott D Solomon, John J V McMurray, Salim Yusuf, Chris B Granger, Carolina Haefliger, Simon de Denus, Jean-Claude Tardif
medRxiv 2021.09.28.21263908; doi: https://doi.org/10.1101/2021.09.28.21263908
Pharmacogenomic study of heart failure and candesartan response from the CHARM programme
Marie-Pierre Dubé, Olympe Chazara, Audrey Lemaçon, Géraldine Asselin, Sylvie Provost, Amina Barhdadi, Louis-Philippe Lemieux Perreault, Ian Mongrain, Quanli Wang, Keren Carss, Dirk S Paul, Jonathan W Cunningham, Jean Rouleau, Scott D Solomon, John J V McMurray, Salim Yusuf, Chris B Granger, Carolina Haefliger, Simon de Denus, Jean-Claude Tardif
medRxiv 2021.09.28.21263908; doi: https://doi.org/10.1101/2021.09.28.21263908
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2822)
- Dermatology (242)
- Emergency Medicine (426)
- Epidemiology (12516)
- Forensic Medicine (10)
- Gastroenterology (798)
- Genetic and Genomic Medicine (4395)
- Geriatric Medicine (399)
- Health Economics (711)
- Health Informatics (2829)
- Health Policy (1043)
- Hematology (372)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4151)
- Nursing (220)
- Nutrition (614)
- Oncology (2186)
- Ophthalmology (622)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (263)
- Palliative Medicine (81)
- Pathology (483)
- Pediatrics (1166)
- Primary Care Research (481)
- Public and Global Health (6733)
- Radiology and Imaging (1480)
- Respiratory Medicine (895)
- Rheumatology (429)
- Sports Medicine (361)
- Surgery (469)
- Toxicology (57)
- Transplantation (198)
- Urology (173)